Background phase correction in congenital heart disease: does reliability vary based on underlying disease type? 
Methods
Retrospectively, we analyzed patients in 4 categories: normal anatomy, stenotic aortic valve, dilated aortic root, and regurgitant pulmonary valve. All patients had PC-MR data obtained on a 1.5T magnet (Siemens MAGNETOM Aera) using a product sequence optimized for pediatric patients with free breathing techniques, multiple signal averages, and the vessel of interest placed at isocenter. We excluded patients with intracardiac shunting, arrhythmias or prosthetic valves. We calculated the aortic to pulmonary flow ratio (Qp:Qs) on 5 different analysis platforms both with and without BPC. Three platforms utilize a full-field stationary tissue fit and two others use a region of interest (ROI) for BPC, which was placed in stationary tissue as close to the vessel of interest as possible. One expert reader performed all vessel segmentations, ensuring all segmentations on different platforms used similar technique. Qp:Qs between 0.9 -1.1 was defined as clinically acceptable.
Results
Fifty patients (76% males, mean age=13 ± 5 years) were analyzed (20 normal, 10 each from the other groups). The intraclass correlation coefficient for intra-observer reliability was 0.99. Distributions of Qp:Qs for different disease categories, before and after BPC, on all platforms are summarized in Table 1 and Figure 1 . Non-corrected (NC) Qp:Qs in normal patients are distributed in the clinically acceptable range. The worst underestimation of Qp:Qs occurred in the regurgitant group, and BPC was significantly beneficial for these patients, with platform 5 being the most efficient. In the dilated aorta group, only the outlier Qp:Qs measurements benefitted from BPC, but the distribution of data were mostly in the acceptable range. BPC could not compensate for outlier measurements in the stenotic aortic valve group, though the medians of distribution did not deviate from 1.0.
Conclusions
Non-corrected phase contrast values vary in clinical accuracy based on underlying disease type, and there are significant differences between various vendors' BPC algorithm efficiencies at resolving these discrepancies. These effects were most pronounced in pediatric patients with regurgitant lesions.
